Importance of Exercise Educational Materials in Chest Physiotherapy

September 27, 2023 updated by: esra pehlivan, Istanbul Medipol University Hospital
The patients who have undergone thoracotomy operation will include in the study. All patients have chest physiotherapy in the intensive care unit. Patients will be randomized and divided into two groups. One group will be given an exercise form with details and photographs of the exercises. No documents will be given to the other group. The program includes breathing exercises, incentive spirometry study, coughing and graded ambulation. After 1 intensive care session, patients are admitted to the service rooms due to routine procedures. The patients will be served in the afternoon and will be questioned whether they are performing their exercises or not.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

  • Physiotherapy will be applied to patients undergoing thoracotomy after 24 hours of intensive care hospitalization.
  • Patients will be randomized and divided into two groups. Study group will be given exercise form. Control group not.
  • Physiotherapy program includes breathing exercises, incentive spirometry study, graded ambulation and both groups will receive this physiotherapy session in the intensive care unit..
  • After the patients are admitted to the service rooms, a service visit will be performed, the amount of remembering of the exercises and whether the exercises are performed in a proper form will be questioned.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Turkey
    • Zeytinburnu
      • Istanbul, Zeytinburnu, Turkey, 34200
        • Yedikule Chest Disease Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Between 18-70 years
  • Having undergone post-thoracotomy
  • Hemodynamically stable,
  • To be conscious

Exclusion Criteria:

  • Excessive pain
  • Neurological complications
  • Cardiovascular and musculoskeletal problems that prevent him from exercising
  • Not wanting to be involved in the study
  • Fever above 38 degrees

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Study Group
Chest physiotherapy + educational material
Other: Chest physiotherapy
All patients will receive chest physiotherapy including "Breathing exercise, intensive spirometry use, coughing, ambulation".
Other: Educational material
Exercise brochure with photos and explanations
Other: Control group
Chest physiotherapy
Other: Chest physiotherapy
All patients will receive chest physiotherapy including "Breathing exercise, intensive spirometry use, coughing, ambulation".

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of exercises remembered
Time Frame: 15 second
The number of remembered exercises will be asked by the patient to show the exercises and recorded by the physiotherapist.
15 second
The number of exercises done correctly
Time Frame: 15 second
The number of exercises done correctly will be asked by the patient to show the exercises and recorded by the physiotherapist.
15 second

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographic features
Time Frame: 5 second
Patients demographic features will be ask to patient
5 second

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istanbul Medipol University Hospital

Investigators

  • Principal Investigator: ESRA PEHLİVAN, PhD, SBÜ

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2024

Primary Completion (Estimated)

September 1, 2024

Study Completion (Estimated)

September 1, 2024

Study Registration Dates

First Submitted

June 18, 2019

First Submitted That Met QC Criteria

June 18, 2019

First Posted (Actual)

June 20, 2019

Study Record Updates

Last Update Posted (Actual)

September 28, 2023

Last Update Submitted That Met QC Criteria

September 27, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Educational material

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physiotherapy

Clinical Trials on Chest physiotherapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe